can retatrutide cause cancer & Pancreatic Research Glucagon-like peptide-1 medicines and cancer
Description
Retrieved January 15, 2026, from Tempia Valenta S, Nicastri A, Perazza F, Marcolini F, Beghelli V, Atti AR, Petroni ML
Coniff R, Krol A
D., OShea D., Gunn I., et al
Conversely, excessive activation of FoxO1 antagonizes the effects of STAT3, dampens the leptin ability to stimulate POMC transcription, and leads to a decreased leptin sensitivity [120]
